trial · primary record
VMD-102
Hepatocellular Carcinoma (HCC)
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 111 |
| Primary completion | 2031-12 |
| Primary endpoint | Number and severity of treatment-emergent adverse events (TEAE) (Phase 1) |
| Registry ID | NCT07636785 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:55:52.855Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07636785
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.